Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibopamine challenge test in glaucoma suspects
ACTRN12615000767505Phase 4Not yet recruiting
- Sponsor
- John Landers
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Ibopamine in Glaucoma, sponsored by John Landers. Primary endpoint: Development of a glaucomatous visual field defect. Planned start Sep 2015; status: not yet recruiting.
02
Drugs
Ibopamine
03
Conditions
Glaucoma
Beyond the preview
Go deeper on ACTRN12615000767505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000767505.